Assyro AI logo background
ectd structure
ectd modules
ectd format
ectd module 1 2 3 4 5
ctd format

eCTD Structure Explained: Complete Guide to Modules 1-5 and Folder Organization

Guide

eCTD structure guide covering all 5 modules, folder hierarchy, XML backbone, and regional formatting. Learn how Module 1, 2, 3, 4, and 5 organize your regulatory submission.

Assyro Team
28 min read

eCTD Structure Explained: Complete Guide to Modules, Folders, and XML Backbone

Quick Answer

The eCTD structure is the standardized organizational framework consisting of five modules (Administrative, Summaries, Quality, Nonclinical, Clinical), an XML backbone for navigation, and a defined folder hierarchy that regulatory agencies worldwide require. Only Module 1 varies by region (FDA, EMA, Health Canada); Modules 2-5 are harmonized globally. Structural errors cause gateway rejections, so mastering the eCTD structure is essential for regulatory submission success.

The eCTD structure is the standardized organizational framework for Electronic Common Technical Document (eCTD) submissions, consisting of five hierarchical modules, an XML backbone for navigation, and a defined folder hierarchy that regulatory agencies worldwide require for drug and biologic applications. The eCTD structure ensures consistent presentation of regulatory data across FDA, EMA, Health Canada, and 60+ other agencies.

Understanding the eCTD structure is fundamental to successful regulatory submissions. A submission that follows perfect formatting but violates structural requirements will be rejected at the gateway. Conversely, mastering the eCTD structure enables faster assembly, easier amendments, and smoother regulatory review.

In this guide, you'll learn:

  • The complete breakdown of eCTD modules 1, 2, 3, 4, and 5 with their specific purposes
  • How the XML backbone creates navigable submission structure
  • The exact folder hierarchy and naming conventions required by ICH M8
  • Regional structural differences between FDA, EMA, and other agencies
  • How the CTD format evolved into the modern eCTD structure

What Is eCTD Structure?

Definition

The eCTD structure is the standardized organizational architecture that defines how pharmaceutical regulatory submissions are assembled, formatted, and presented to health authorities. It encompasses three interconnected layers: five-module content organization, an XML backbone that provides navigation, and a file system hierarchy containing all documents, with Modules 2-5 harmonized globally and Module 1 varying by regulatory authority.

The eCTD structure is the standardized organizational architecture that defines how pharmaceutical regulatory submissions are assembled, formatted, and presented to health authorities. This structure encompasses three interconnected layers: the five-module content organization, the XML backbone that provides navigation, and the file system hierarchy that contains all documents.

Key characteristics of eCTD structure:

  • Five-module organization based on ICH M4 Common Technical Document
  • XML backbone files (index.xml, regional.xml) providing navigable structure
  • Standardized folder naming following ICH M8 specifications
  • Leaf-level document organization within each module
  • Lifecycle management through sequence numbering
  • Harmonized content structure (Modules 2-5) with regional variation (Module 1)
Key Statistic

The eCTD structure was first published as ICH M8 in 2003 and has been updated through multiple versions, with eCTD v3.2.2 being the most widely implemented and eCTD v4.0 introducing significant structural enhancements.

The eCTD structure serves two critical purposes: it provides regulatory reviewers with a predictable, navigable organization for efficient assessment, and it enables sponsors to manage complex submissions with thousands of documents across global markets.

The CTD Format: Foundation of eCTD Structure

The CTD format (Common Technical Document format) is the organizational blueprint that the eCTD structure implements electronically. Understanding the CTD format is essential because the eCTD directly mirrors its content organization.

History of the CTD Format

The CTD format emerged from the International Council for Harmonisation (ICH) effort to standardize regulatory submissions across regions:

YearMilestoneImpact on Structure
1996ICH M4 working group formedBegan defining common structure
2000CTD specification finalizedEstablished 5-module organization
2003eCTD v1.0 published (ICH M8)Electronic implementation defined
2008eCTD v3.2 releasedRefined structural requirements
2016eCTD v4.0 specificationIntroduced XML-based structure
2024eCTD v4.0 regional adoptionFDA and other agencies implementing

The CTD Triangle

The CTD triangle is a visual representation of how submission content flows from detailed data to summarized overviews:

[@portabletext/react] Unknown block type "code", specify a component for it in the `components.types` prop

This structure enables reviewers to start with summaries (Module 2) and drill down into supporting detail (Modules 3, 4, 5) as needed.

CTD Format vs eCTD Structure

AspectCTD FormateCTD Structure
MediumPaper-basedElectronic (XML + PDF)
NavigationPhysical tabs and dividersXML backbone hyperlinks
Module organizationSame 5-module structureSame 5-module structure
File formatPaper or PDF bindersPDF with XML metadata
UpdatesComplete section replacementGranular leaf operations
Lifecycle trackingManual version controlSequence-based tracking
Current usageLegacy onlyGlobal standard

Complete eCTD Modules Breakdown

The eCTD structure organizes all submission content into five modules. Understanding each module's purpose and content is essential for proper eCTD structure implementation.

eCTD Module Overview Table

ModuleNameContent FocusRegional StatusTypical Size
Module 1Administrative InformationForms, labeling, correspondenceRegion-specific50-200 docs
Module 2Common Technical Document SummariesQuality, nonclinical, clinical overviewsHarmonized30-50 docs
Module 3QualityDrug substance and drug product CMCHarmonized200-1000 docs
Module 4Nonclinical Study ReportsPharmacology, PK, toxicologyHarmonized50-300 docs
Module 5Clinical Study ReportsAll clinical studies and dataHarmonized500-5000+ docs

Module 1: Administrative Information and Prescribing Information

Module 1 is the only region-specific module in the eCTD structure. Its organization differs between FDA, EMA, Health Canada, and other regulatory authorities.

Module 1 Purpose:

  • Contains all administrative documents required by the specific regulatory authority
  • Houses product labeling in the regional format
  • Includes regulatory correspondence and forms
  • Provides region-specific information not included in harmonized modules

FDA Module 1 Structure:

SectionContentKey Documents
1.1FormsFDA 356h, 1571, 3674
1.2Cover LetterSubmission cover letter
1.3Administrative InformationPatent info, exclusivity, fees
1.4ReferencesLiterature not in Module 5
1.5Application StatusField copy certification
1.6-1.10Regional AdministrativeFinancial disclosure, PDUFA
1.11Pediatric AdministrativePediatric assessments
1.12OtherREMS, promotional materials
1.14LabelingUSPI, patient labeling, labels
1.15Promotional MaterialsAdvertising and promotional items
1.16Risk ManagementRisk mitigation materials

EMA Module 1 Structure:

SectionContentKey Documents
1.0Cover LetterApplication cover letter
1.2Application FormEMA forms
1.3Product InformationSmPC, Annex II, Package Leaflet
1.4Expert StatementsQP declarations
1.5Specific InformationSpecial requirements
1.6Environmental RiskERA documentation
1.7Orphan InformationOrphan designation documents
1.8PharmacovigilancePSMF, RMP reference
1.9Clinical TrialsEudraCT references
1.10ResponsesResponse to questions
Pro Tip

Always create your Module 1 structure based on your submission's specific regulatory path before authoring begins. FDA, EMA, and Health Canada require different section numbering and documents. Pre-planning your Module 1 structure prevents last-minute reorganization that delays submission and introduces errors.

Module 2: Common Technical Document Summaries

Module 2 provides the summaries and overviews that reviewers read first. This module synthesizes all data from Modules 3, 4, and 5 into accessible narrative form.

Module 2 Structure:

SectionTitleContentCross-References To
2.1CTD Table of ContentsNavigation indexEntire submission
2.2CTD IntroductionProduct overviewAll modules
2.3Quality Overall Summary (QOS)CMC summaryModule 3
2.4Nonclinical OverviewNonclinical interpretationModule 4
2.5Clinical OverviewClinical interpretationModule 5
2.6Nonclinical Written and Tabulated SummariesDetailed nonclinical summaryModule 4
2.7Clinical SummaryDetailed clinical summaryModule 5

Module 2.3 Quality Overall Summary Subsections:

SubsectionContent
2.3.SDrug Substance summary
2.3.S.1General information
2.3.S.2Manufacture
2.3.S.3Characterization
2.3.S.4Control of drug substance
2.3.S.5Reference standards
2.3.S.6Container closure system
2.3.S.7Stability
2.3.PDrug Product summary
2.3.P.1Description and composition
2.3.P.2Pharmaceutical development
2.3.P.3Manufacture
2.3.P.4Control of excipients
2.3.P.5Control of drug product
2.3.P.6Reference standards
2.3.P.7Container closure system
2.3.P.8Stability
2.3.AAppendices
2.3.RRegional information

Module 3: Quality (Chemistry, Manufacturing, and Controls)

Module 3 contains the complete Chemistry, Manufacturing, and Controls (CMC) data for both drug substance and drug product. This module follows the ICH M4Q structure.

Module 3 Structure:

SectionTitleContent Type
3.2.SDrug Substance
3.2.S.1General InformationNomenclature, structure, properties
3.2.S.2ManufactureProcess description, controls, validation
3.2.S.3CharacterizationStructure elucidation, impurities
3.2.S.4Control of Drug SubstanceSpecifications, analytical methods, batch data
3.2.S.5Reference StandardsPrimary and secondary standards
3.2.S.6Container Closure SystemPackaging description and suitability
3.2.S.7StabilityStability protocol, data, and summary
3.2.PDrug Product
3.2.P.1Description and CompositionDosage form, formulation
3.2.P.2Pharmaceutical DevelopmentFormulation, process development
3.2.P.3ManufactureProcess, controls, validation
3.2.P.4Control of ExcipientsExcipient specifications
3.2.P.5Control of Drug ProductSpecifications, methods, batch data
3.2.P.6Reference StandardsProduct-related standards
3.2.P.7Container Closure SystemPrimary and secondary packaging
3.2.P.8StabilityStability data and commitments
3.2.AAppendicesSupporting data
3.2.A.1Facilities and EquipmentSite information
3.2.A.2Adventitious Agents SafetyBiological safety data
3.2.A.3ExcipientsNovel excipient information
3.2.RRegional InformationRegion-specific CMC data

Module 4: Nonclinical Study Reports

Module 4 contains all nonclinical (animal and in vitro) studies following the ICH M4S structure. This module organizes pharmacology, pharmacokinetics, and toxicology data.

Module 4 Structure:

SectionTitleStudy Types Included
4.2.1Pharmacology
4.2.1.1Primary PharmacodynamicsMechanism of action studies
4.2.1.2Secondary PharmacodynamicsOff-target effect studies
4.2.1.3Safety PharmacologyCV, CNS, respiratory safety
4.2.1.4Pharmacodynamic Drug InteractionsPD DDI studies
4.2.2Pharmacokinetics
4.2.2.1Analytical MethodsBioanalytical validation
4.2.2.2AbsorptionAbsorption studies
4.2.2.3DistributionTissue distribution, protein binding
4.2.2.4MetabolismIn vitro and in vivo metabolism
4.2.2.5ExcretionMass balance, excretion routes
4.2.2.6Pharmacokinetic Drug InteractionsPK DDI studies
4.2.2.7Other Pharmacokinetic StudiesAdditional PK data
4.2.3Toxicology
4.2.3.1Single-Dose ToxicityAcute toxicity studies
4.2.3.2Repeat-Dose ToxicitySubacute, subchronic, chronic
4.2.3.3GenotoxicityIn vitro and in vivo genotox
4.2.3.4CarcinogenicityLong-term carcinogenicity
4.2.3.5Reproductive ToxicityFertility, EFD, PPND studies
4.2.3.6Local ToleranceInjection site, dermal studies
4.2.3.7Other Toxicity StudiesImmunotox, phototox, mechanistic

Module 5: Clinical Study Reports

Module 5 is typically the largest module, containing all clinical study reports and supporting clinical data following ICH E3 format requirements.

Module 5 Structure:

SectionTitleContent Type
5.2Tabular Listing of Clinical StudiesIndex of all studies
5.3.1Biopharmaceutic Studies
5.3.1.1Bioavailability StudiesBA study reports
5.3.1.2Comparative BA and BE StudiesBE study reports
5.3.1.3In Vitro-In Vivo CorrelationIVIVC studies
5.3.1.4Bioanalytical MethodsClinical bioanalysis validation
5.3.2PK Using Human Biomaterials
5.3.2.1Plasma Protein BindingProtein binding studies
5.3.2.2Hepatic MetabolismIn vitro metabolism
5.3.2.3Drug InteractionsIn vitro DDI studies
5.3.3PK and Initial Tolerability
5.3.3.1Healthy Subject PKPhase 1 PK studies
5.3.3.2Patient PKPatient population PK
5.3.3.3Intrinsic FactorsRenal/hepatic impairment
5.3.3.4Extrinsic FactorsDDI clinical studies
5.3.3.5Population PKPopPK analyses
5.3.4Pharmacodynamics
5.3.4.1Healthy Subject PDPD studies in healthy volunteers
5.3.4.2Patient PD and PK/PDPK/PD modeling, patient PD
5.3.5Efficacy and Safety
5.3.5.1Efficacy/Safety - Controlled StudiesPivotal efficacy trials
5.3.5.2Efficacy/Safety - Uncontrolled StudiesSupportive studies
5.3.5.3Analyses Across StudiesISS, ISE, pooled analyses
5.3.5.4Other Efficacy/Safety StudiesRegistry, observational
5.3.6Post-Marketing
5.3.6Post-Marketing ReportsPost-market safety data
5.3.7CRFs and Individual Patient Data
5.3.7Case Report FormsCRFs and listings
5.4Literature ReferencesPublished literature

eCTD Folder Hierarchy and File Organization

The eCTD structure defines exact folder naming conventions and file organization that must be followed precisely. This folder hierarchy enables automated validation and consistent navigation.

Root Level Folder Structure

The eCTD uses sequence folders at the root level to track submission lifecycle:

[@portabletext/react] Unknown block type "code", specify a component for it in the `components.types` prop

Module Folder Naming Conventions

Each module follows specific folder naming rules defined by ICH M8:

Module 1 Folder Structure (FDA Example):

[@portabletext/react] Unknown block type "code", specify a component for it in the `components.types` prop

Module 2 Folder Structure:

[@portabletext/react] Unknown block type "code", specify a component for it in the `components.types` prop

Module 3 Folder Structure:

[@portabletext/react] Unknown block type "code", specify a component for it in the `components.types` prop

File Naming Requirements

The eCTD structure enforces strict file naming conventions:

RuleRequirementExample
Character limitMaximum 64 characters including extension`clinical-study-report.pdf`
Allowed charactersLowercase a-z, digits 0-9, hyphen`study-001-csr.pdf`
Prohibited charactersSpaces, uppercase, special charactersNOT `Study 001 CSR.pdf`
Extension caseLowercase only`.pdf` not `.PDF`
Path limitTotal path should not exceed 180 characters-

File Naming Comparison:

CompliantNon-CompliantReason
`efficacy-study-001.pdf``Efficacy Study 001.pdf`Uppercase and spaces
`module-2-3-qos.pdf``module 2.3 QOS (final).pdf`Spaces and parentheses
`batch-analysis-12345.pdf``batch_analysis_12345.PDF`Underscore and uppercase extension
`csr-pk-phase1.pdf``CSR PK Phase I (v2.0).pdf`Multiple violations
Pro Tip

Implement file naming conventions early in your document authoring process. Create a naming standard document and share it with all contributors (writers, scientists, regulatory). This prevents expensive late-stage file renaming and ensures consistency across thousands of submission documents.

eCTD XML Backbone Structure

The XML backbone is the navigation layer of the eCTD structure. It creates the hyperlinked table of contents that enables reviewers to navigate through thousands of documents.

XML Backbone Components

XML FilePurposeContains
`index.xml`Master navigationLinks to all modules and regional XML
`us-regional.xml`FDA-specific metadataUS Module 1 information
`eu-regional.xml`EMA-specific metadataEU Module 1 information
`ca-regional.xml`Health Canada metadataCanadian Module 1 information

Index.xml Structure

The index.xml file serves as the entry point for the entire submission:

[@portabletext/react] Unknown block type "code", specify a component for it in the `components.types` prop

Leaf Elements

Leaves are the fundamental building blocks of the eCTD XML structure. Each leaf represents one document:

Leaf Attributes:

AttributePurposeRequired
`ID`Unique identifier for the documentYes
`operation`Lifecycle operation (new, replace, append, delete)Yes
`checksum`MD5 hash for file integrityYes
`checksum-type`Always "md5"Yes
`xlink:href`Relative path to the documentYes
`modified-file`Original leaf ID when replacingFor replace operations

Lifecycle Operations:

OperationDescriptionUse Case
`new`First time document appearsInitial submission
`replace`Replaces entire documentUpdated version
`append`Adds content to existing documentAdditional data
`delete`Removes document from submissionWithdrawn content

MD5 Checksum Verification

Every document in the eCTD structure must have a valid MD5 checksum:

Key Statistic

MD5 checksums are 128-bit hash values that uniquely identify file content. If even one byte changes in a file, the entire checksum changes, enabling detection of file corruption or unauthorized modification.

Checksum Generation Process:

  1. Calculate MD5 hash of the PDF file
  2. Record 32-character hexadecimal string in leaf element
  3. Verify checksum after any file operation
  4. Regenerate if file is modified

Regional eCTD Structure Differences

While Modules 2-5 follow harmonized ICH structure globally, significant differences exist in Module 1 organization and regional XML requirements.

FDA vs EMA vs Health Canada Structure Comparison

Structural ElementFDA (US)EMA (EU)Health Canada
eCTD Versionv3.2.2 / v4.0v3.2.2v3.2.2
Regional DTDus-regional.dtdeu-regional.dtdca-regional.dtd
Module 1 Organization1.1-1.16 sections1.0-1.10 sections1.0-1.7 sections
Labeling Section1.141.3.11.3.1
Financial DisclosureRequired (1.8)Not requiredNot required
Environmental AssessmentRequired (1.6)Required (1.6.1)Not required
Expert DeclarationsNot requiredRequired (1.4)Not required
Patent InformationRequired (1.3.1)Not in M1Not required

Regional Module 1 Numbering

FDA Module 1 Numbering:

[@portabletext/react] Unknown block type "code", specify a component for it in the `components.types` prop

EMA Module 1 Numbering:

[@portabletext/react] Unknown block type "code", specify a component for it in the `components.types` prop

eCTD v4.0 Structural Changes

eCTD v4.0 introduces significant structural enhancements:

FeatureeCTD v3.2.2eCTD v4.0
Backbone formatDTD-based XMLSchema-based XML (XSD)
Controlled vocabularyLimitedExtensive CV lists
Document lifecycleLeaf operationsEnhanced tracking
Study taggingSTF separateIntegrated
MetadataBasicExtended attributes
ValidationDTD validationSchema + Schematron

eCTD Structure Best Practices

Following eCTD structure best practices ensures submission success and efficient regulatory review.

Document Organization Best Practices

  1. Plan structure early - Map your documents to eCTD sections during development
  2. Use consistent naming - Establish file naming conventions before authoring
  3. Maintain granularity - Keep documents at appropriate sizes (5-50 MB typical)
  4. Group related content - Use the structure logically, not just technically
  5. Track versions - Document which version corresponds to which leaf ID

Cross-Reference Best Practices

PracticeBenefit
Use relative paths onlyEnsures portability across systems
Test all hyperlinksPrevents broken link errors
Maintain case sensitivityAvoids Linux server issues
Update bookmarks when content changesKeeps navigation accurate
Verify cross-module referencesEnsures M2/M3 consistency

Lifecycle Management Best Practices

Sequence Strategy:

  • Use sequence 0000 for initial submission
  • Increment sequences chronologically (0001, 0002...)
  • Never skip sequence numbers
  • Document sequence purpose in cover letters

Leaf Operations Strategy:

  • Use new only for truly new documents
  • Use replace for updated versions (maintains audit trail)
  • Use delete sparingly (may raise questions)
  • Use append only when adding to existing content
Pro Tip

When responding to FDA information requests (Type A meetings, 90-day letters), create a new sequence folder (0001, 0002, etc.) with only the changed documents. Don't include unchanged documents in your response sequence. This makes your response focused and easier for reviewers to navigate, and it documents exactly which documents you updated in response to specific questions.

Key Takeaways

The eCTD structure is the standardized organizational framework for Electronic Common Technical Document submissions, consisting of five modules (Administrative, Summaries, Quality, Nonclinical, Clinical), an XML backbone for navigation, and a defined folder hierarchy. This structure is required by FDA, EMA, Health Canada, and 60+ regulatory agencies worldwide for drug and biologic applications.

Key Takeaways

  • The eCTD structure consists of five modules: Module 1 (regional administrative), Module 2 (summaries), Module 3 (CMC/quality), Module 4 (nonclinical), and Module 5 (clinical), with only Module 1 varying between regulatory authorities.
  • The XML backbone provides navigation: The index.xml file creates a hyperlinked table of contents using leaf elements that contain document metadata, checksums, and lifecycle operation indicators.
  • Folder hierarchy follows strict conventions: ICH M8 defines exact folder naming, file naming (64 characters max, lowercase, no spaces), and path organization that must be followed precisely to pass gateway validation.
  • Regional differences concentrate in Module 1: FDA, EMA, and Health Canada each have different Module 1 section numbering, required documents, and regional DTD files, while Modules 2-5 remain harmonized.
  • eCTD v4.0 modernizes the structure: The next-generation format introduces XSD schemas, extended metadata, controlled vocabularies, and improved lifecycle tracking while maintaining the five-module organization.
  • ---

Next Steps

Understanding the eCTD structure is essential for regulatory submission success, but implementing it correctly across thousands of documents requires systematic validation. Structural errors cause gateway rejections and delay your drug approval timeline.

Need help validating your eCTD structure? Assyro's AI-powered platform validates your submission against all ICH M8 structural requirements, checking folder hierarchy, file naming, XML backbone integrity, and cross-module consistency before you submit. Catch structural errors before they become gateway rejections.

See How Assyro Validates eCTD Structure - Request a Demo

Sources